Page 15 - Vasoclick emagazine Issue2
P. 15

Vasoclick, Edition 2                                                                                 14


               The potential  of biologics  and small
               molecule inhibitors in the context of incident
               VTE and  PVD  for their anti-inflammatory

               effects is a budding avenue for research. 2



           References:

           1) Garshick MS, Ward NL, Krueger JG, Berger JS. Cardio-
           vascular risk in patients with psoriasis: JACC Review
           Topic of the Week. J Am Coll Cardiol.
           2021;77(13):1670-1680. doi:10.1016/j.jacc.2021.02.009

           2) Chen TL, Lee LL, Huang HK, et al. Association of
           psoriasis with incident venous thromboembolism and
           peripheral vascular disease: a systematic review and
           meta-analysis. JAMA Dermatol. 2022;158(1):59-67.
           doi:10.1001/jamadermatol.2021.4918

           3) Elmets CA, Leonardi CL, Davis DMR, et al. Joint
           AAD-NPF guidelines of care for the management and
           treatment of psoriasis with awareness and attention to
           comorbidities. J Am Acad Dermatol.
           2019;80(4):1073-1113. doi:10.1016/j.jaad.2018.11.058

           4) Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of
           observational studies in epidemiology: a proposal for
           reporting. Meta-analysis Of Observational Studies in
           Epidemiology (MOOSE) group. JAMA.
           2000;283(15):2008-2012. doi:10.1001/jama.283.15.2008
           5) Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA
           2020 statement: an updated guideline for reporting
           systematic reviews. BMJ. 2021;372:n71. Published 2021
           Mar 29. doi:10.1136/bmj.n71

           6) Lockshin B, Balagula Y, Merola JF. Interleukin 17,
           inflammation, and cardiovascular risk in patients with
           psoriasis. J Am Acad Dermatol. 2018;79(2):345-352.
           doi:10.1016/j.jaad.2018.02.040

           7) Fan Z, Wang L, Jiang H, Lin Y, Wang Z. Platelet dysfunc-
           tion and its role in the pathogenesis of psoriasis. Derma-
           tology. 2021;237(1):56-65. doi:10.1159/000505536

           8) Krueger JG, Brunner PM. Interleukin-17 alters the
           biology of many cell types involved in the genesis of
           psoriasis, systemic inflammation and associated comor-
           bidities. Exp Dermatol. 2018;27(2):115-123.
           doi:10.1111/exd.13467

           9) Armstrong AW, Voyles SV, Armstrong EJ, Fuller EN,
           Rutledge JC. Angiogenesis and oxidative stress: common
           mechanisms linking psoriasis with atherosclerosis. J
           Dermatol Sci. 2011;63(1):1-9. doi:10.1016/j.jderms-
           ci.2011.04.007
   10   11   12   13   14   15   16   17   18   19   20